David W. Gibbs

Board Member

Equibles does not estimate personal net worth.

Get an email with a short summary when Amgen Inc publishes a filing, an earnings call transcript or a press release.

About David W. Gibbs

David W. Gibbs is recorded as Board Member at Amgen Inc (AMGN) since October 26, 2026. Amgen Inc reported in an 8-K filed October 27, 2026 that David W. Gibbs was appointed director, effective October 26, 2026. Amgen Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Amgen Inc includes Robert Bradway (CEO), David W. Meline (CFO), Thomas Dittrich (CFO) and 7 others.

“On October 26, 2026, the Board of Directors (the “Board”) of Amgen Inc. (the “Company”) appointed David W. Gibbs as a director of the Company, effective immediately.”

Amgen Inc Form 8-K, filed October 27, 2026 · Read the filing

Affiliation history

Amgen Inc (AMGN)
Board Member

SEC 8-K

Current
2026-10-26–present

Company network

Amgen Inc

AMGN

Current role

Drug Manufacturers - General · Healthcare

Board Member

2026-10-26–present

Leadership on record at Amgen Inc

Robert Bradway CEO
David W. Meline CFO
Thomas Dittrich CFO
David M. Reese, M.D. CTO
Sean Bruich CTO
Jonathan P. Graham General Counsel
Linda H. Louie Chief Accounting Officer
Matthew C. Busch Chief Accounting Officer
Amy E. Miles Board Member
Michael V. Drake Board Member

Recent activity

Executive change Appointed: director Amgen Inc (AMGN)
2026-10-26